NAD is a cellular coenzyme, not a peptide. Epitalon is discussed in peptide research. Grouping them as equivalent “longevity peptides” obscures differences in chemistry, biological questions and the evidence needed to support a health claim.

Human studies of nicotinamide riboside, an NAD precursor, examine particular populations and outcomes. A small randomized trial in people with mild cognitive impairment, for example, studied a defined oral intervention. Its findings cannot be transferred directly to NAD infusions or a claim that lifespan is extended. Nicotinamide riboside pilot randomized trial in cognitive impairment

A biomarker is not the outcome itself

Changing a metabolite level or a laboratory marker can show that an intervention has biological activity. It does not automatically establish better function, less disease or longer survival. Those outcomes need appropriate measurement and follow-up.

Epitalon-related research includes experiments on chromatin in cultured cells. Cells obtained from people are still an ex vivo model when treated outside the body. Such work does not demonstrate that administering the compound reverses aging in people. Peptide bioregulators and chromatin in cultured lymphocytes

Safety must be assessed separately

A biological rationale for a benefit does not establish an acceptable risk profile. FDA has described limited safety information and potential immunogenicity concerns for epitalon preparations. That safety assessment is distinct from changing compounding policy or from a laboratory observation. FDA safety concerns for nominated compounding substances

To compare aging research responsibly, specify the intervention, route, population, comparator and meaningful endpoint. Do not combine results from a supplement trial, a cell experiment and an infusion service into one evidence category.

AXON does not rank NAD-related interventions against epitalon as proven longevity treatments. The useful conclusion is that the studies address different questions, and none of the sources reviewed here establishes a general anti-aging prescription or a human lifespan benefit from the products commonly marketed under those labels.